PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Stanford scientists identify key protein controlling blood vessel growth into brains of mice

2010-11-12
(Press-News.org) STANFORD, Calif. — One protein single-handedly controls the growth of blood vessels into the developing brains of mice embryos, according to researchers at the Stanford University School of Medicine. Understanding how the protein, a cellular receptor, functions could help clinicians battle brain tumors and stroke by choking off or supplementing vital blood-vessel development, and may enhance the delivery of drugs across the blood-brain barrier.

"The strength and specificity of this receptor's effects indicate that it could be a very important target," said Calvin Kuo, MD, PhD, associate professor of medicine. "It's really a spectacular phenotype. For a stroke, we might want to stimulate the function of this receptor; for a brain tumor, we might want to inhibit it."

Kuo is the senior author of the research, which will be published Nov. 12 in Science. Frank Kuhnert, PhD, a research associate in the Kuo lab, is the first author of the work. The research was supported in part by the Stanford Center for Children's Brain Tumors.

The protein, called GPR124, is a member of a family of proteins called G-protein-coupled receptors that span the cellular membrane. Each receptor has a protein partner called a ligand that is secreted into the extracellular space — usually by a different cell. When a ligand binds to its receptor, it causes a cascade of events within that cell. In this way, the secreted ligand allows cells to "talk" to one another across distances to coordinate many aspects of development and metabolism.

There are hundreds of different G-protein-coupled receptors, and the functions of many have been identified. GPR124, however, is relatively unusual in that an exceptionally large portion of the protein projects out of the membrane into the extracellular space. Kuo and his colleagues, who study how tumors recruit blood vessels to nourish and sustain them, were drawn to it because it has previously been shown to be involved in tumor blood vessels, though nobody knew specifically what it did.

The researchers began by looking to see where in an adult mouse the receptor was normally expressed. They discovered that it is found almost exclusively on the endothelial cells of the brain and the central nervous system. (Endothelial cells line blood vessels throughout the body and help blood to flow more smoothly.) When the researchers bred mice lacking the ability to express GPR124, they died as embryos after about 15 days of gestation. Looking at cross-sections of their brains, it was easy to see why.

"These embryos did not have any blood vessels entering their forebrains or developing spinal cords at all," said Kuo. "And the effects were very specific for the nervous system since all other organs had normal blood vessel development." The forebrain includes the cerebral cortex, which plays a key role in memory, attention, consciousness and thought. In contrast, control mice embryos, with normal expression of GPR124, began developing brain blood vessels by about 11.5 days.

Interestingly, the researchers noticed that the timing of vessel development coincided with the formation of a physiological security checkpoint called the blood-brain barrier. The barrier, which is due in part to particularly tight junctions between individual epithelial cells in blood vessels in the central nervous system, ensures that only select molecules such as oxygen and glucose have access to the brain, and bars the entry of bacteria or larger molecules. Unfortunately, it can also block the entry of essential drugs to treat cancer or stroke, and in some diseases, such as multiple sclerosis, it inappropriately admits self-reactive immune cells that attack brain tissue.

To investigate the coincidence, Kuo and Kuhnert teamed up with graduate student Michael Mancuso to show that GPR124 expression is required in endothelial cells to regulate expression of a protein called Glut1 known to be involved in the development of the blood-brain barrier. The results suggest that GPR124 also plays a role in barrier development.

Kuo and Kuhnert next overexpressed GPR124 in the mice and followed their development. While the mice at first seemed normal, they began to develop large tangles of blood vessels in their forebrains as they aged. After about one year, nearly 70 percent of the mice displayed this kind of abnormal hypervasculature — but only in their brains. The results show that the action of GPR124 is highly specific for the central nervous system.

Still, the identity of the receptor's ligand remains a mystery. Kuo and his colleagues teamed up with researchers from Stanford's School of Engineering to narrow down the options. They used a microfluidic chamber — a technique that, among other things, allows the analysis of single-cell behavior — specially constructed by graduate student Amir Shamloo to investigate how mouse endothelial cells expressing GPR124 reacted to cells from different parts of the brain. Shamloo works in the lab of Sarah Heilshorn, PhD, assistant professor in materials science and engineering.

The researchers placed the cells in the middle of the chamber, and filled the channels on either side with these extracts from the forebrain — where the receptor's effects seem to be concentrated — or the hindbrain, where the receptor is not essential. They found that the endothelial cells only migrated toward the extract from the forebrain, much like the blood vessels grow toward and penetrate the embryonic brain during development.

"This was a key turning point," Kuo said of the collaboration. "We struggled for years to model the action of this receptor in vitro, but we couldn't do it without these microfluidic chambers."

In the future, the researchers plan to use mice in which they can toggle the expression of GPR124 on and off at will to examine its role in brain tumor development and stroke. They also hope to learn more about whether GPR124 is involved in the formation of the blood-brain barrier.

"There are a tremendous number of disorders that could be affected by GPR124 expression," said Kuo. "We're excited to begin those studies."

###

Other Stanford researchers involved in the study include graduate student Hsiao-Ting, undergraduate Vir Choksi and postdoctoral scholar Mareike Florek, PhD. Additional funding for the research came from the National Institutes of Health, American Heart Association, UK Medical Research Council, Brain Tumor Society and Goldhirsh Foundation. Information about the Departments of Medicine, of Mechanical Engineering and of Bioengineering, which also supported the research, is available at http://medicine.stanford.edu/, http://me.stanford.edu/ and http://bioengineering.stanford.edu/.

The Stanford University School of Medicine consistently ranks among the nation's top medical schools, integrating research, medical education, patient care and community service. For more news about the school, please visit http://mednews.stanford.edu. The medical school is part of Stanford Medicine, which includes Stanford Hospital & Clinics and Lucile Packard Children's Hospital. For information about all three, please visit http://stanfordmedicine.org/about/news.html.

END



ELSE PRESS RELEASES FROM THIS DATE:

Fortify HIT contracts with education and ethics to protect patient safety, say informatics experts

2010-11-12
Bethesda, MD—An original and progressive report on health information technology (HIT) vendors, their customers and patients, published online today, makes ground-breaking recommendations for new practices that target the reduction or elimination of tensions that currently mar relationships between many HIT vendors and their customers, specifically with regard to indemnity and error management of HIT systems. In light of the Obama Administration's $19 billion investment in HIT, paid out in ARRA stimulus funds, these recommendations are particularly significant in helping ...

Graphene's strength lies in its defects

Graphenes strength lies in its defects
2010-11-12
PROVIDENCE, R.I. [Brown University] — The website of the Nobel Prize shows a cat resting in a graphene hammock. Although fictitious, the image captures the excitement around graphene, which, at one atom thick, is the among the thinnest and strongest materials ever produced. A significant obstacle to realizing graphene's potential lies in creating a surface large enough to support a theoretical sleeping cat. For now, material scientists stitch individual graphene sheets together to create sheets that are large enough to investigate possible applications. Just as sewing ...

New analysis explains formation of bulge on far side of moon

2010-11-12
SANTA CRUZ, CA--A bulge of elevated topography on the farside of the moon--known as the lunar farside highlands--has defied explanation for decades. But a new study led by researchers at the University of California, Santa Cruz, shows that the highlands may be the result of tidal forces acting early in the moon's history when its solid outer crust floated on an ocean of liquid rock. Ian Garrick-Bethell, an assistant professor of Earth and planetary sciences at UC Santa Cruz, found that the shape of the moon's bulge can be described by a surprisingly simple mathematical ...

Contact among age groups key to understanding whooping cough spread and control

2010-11-12
ANN ARBOR, Mich.---Strategies for preventing the spread of whooping cough---on the rise in the United States and several other countries in recent years---should take into account how often people in different age groups interact, research at the University of Michigan suggests. The findings appear in the Nov. 12 issue of the journal Science. Thanks to widespread childhood vaccination, whooping cough (pertussis) once seemed to be under control. But the illness, which in infants causes violent, gasping coughing spells, has made a comeback in some developed countries ...

Fruit flies lead scientists to new human pain gene

2010-11-12
Boston, Mass. - While it has become clear in recent years that susceptibility to pain has a strong inherited component, very little is known about actual "pain genes" and how they work. In the November 12th issue of Cell, researchers at Children's Hospital Boston and their collaborators report on a novel human pain gene. People with minor variations in this gene showed clear differences in susceptibility to acute heat pain and chronic back pain. Corroborating mouse studies give some clues as to how the gene controls pain sensitivity. The gene was uncovered in a genome-wide ...

All-optical transistor

All-optical transistor
2010-11-12
Controlling and modulating the flow of light is essential in today's telecommunications-based society. Professor Tobias Kippenberg and his team in EPFL's Laboratory of Photonics and Quantum Measurements have discovered a novel way to couple light and vibrations. Using this discovery, they built a device in which a beam of light traveling through an optical microresonator could be controlled by a second, stronger light beam. The device thus acts like an optical transistor, in which one light beam influences the intensity of another. Their optical microresonator has two ...

Having severe acne may increase suicide risk

2010-11-12
Individuals who suffer from severe acne are at an increased risk of attempting suicide, according to a paper published on bmj.com today. The study also finds that an additional risk may be present during and up to one year after treatment with isotretinoin, a commonly prescribed drug for severe acne. However, the authors stress that this additional risk is most likely due to the acne itself, rather than the drug treatment. Isotretinoin (commonly marketed as Roaccutane, Accutane, Amnesteem, Claravis, Clarus or Decutan) has been used to treat severe acne since the 1980s. ...

Thousands of turtles captured in Madagascar despite ban

Thousands of turtles captured in Madagascar despite ban
2010-11-12
New research has revealed up to 16,000 endangered turtles are being caught each year by villagers in just one region of Madagascar, despite a government ban. Researchers from the University of Exeter and Blue Ventures Conservation say the figure, thought to be a conservative estimate, is the first direct assessment of turtle exploitation on the island. The study highlights the extent of small-scale fishing, traditionally very difficult to monitor, and could be vital in finding a way to sustainably manage turtle fishing in the region. Dr Annette Broderick, from the ...

Study points to window of opportunity for successful autism therapy

2010-11-12
"The biggest surprise to me was that we could rescue the autistic phenotype [in the human cells] to something close to normal," said Alysson Muotri of the University of California San Diego. The researchers made the discovery by first transforming adult cells taken from patients with Rett Syndrome into induced pluripotent stem cells (iPS cells) using an established cocktail. iPS cells look and act very much like embryonic stem cells. Those stem cells were able to form functional neurons in cell culture. However, neurons derived from Rett Syndrome patients exhibited ...

A long history of pain: Study finds pain gene common to flies, mice and humans

2010-11-12
They show that one of those genes in particular has a long evolutionary history, as evidenced by the fact that it plays a role in pain sensing in flies, mice and humans. At least in mice, the newly described gene is also linked to a condition known in humans as synesthesia, in which one sensory experience triggers the perception of another sense. "We found lots of new genes and pathways that have never been implicated in pain before," said Josef Penninger of the Institute of Molecular Biotechnology of the Austrian Academy of Sciences. "From a helicopter view, this ...

LAST 30 PRESS RELEASES:

New jab protects babies from serious lung infection, study shows

July Tip Sheet from Sylvester Comprehensive Cancer Center

Current application status and innovative development of surgical robot

Counterfeited in China: New book assesses state of industry and its future

Machine learning reveals historical seismic events in the Yellowstone caldera

First analyses of Myanmar earthquake conclude fault ruptured at supershear velocity

Curved fault slip captured on CCTV during Myanmar earthquake

Collaboration rewarded for work to further deployment of batteries in emerging economies

Heart-healthy habits also prevent cancer, Alzheimer’s, COPD, other diseases, Emory study finds

Scientists will use a $1M grant to build a support system addressing sea level rise and flooding in South Florida

New research examines how pH impacts the immune system

Inhaled agricultural dust disrupts gut health

New study reveals hidden regulatory roles of “junk” DNA

Taking the sting out of ulcerative colitis

Deep life’s survival secret: Crustal faulting generates key energy sources, study shows

Idaho National Laboratory to lead advancements in US semiconductor manufacturing

AI-assisted sorting, other new technologies could improve plastic recycling

More than just larks and owls!

Call for nominations: 2026 Dan David Prize

New tool gives anyone the ability to train a robot

Coexistence of APC and KRAS mutations in familial adenomatous polyposis and endometrial cancer: A mini-review with case-based perspective

First global-to-local study reveals stark health inequalities from COVID-19 in 2020–2021

rcssci: Simplifying complex data relationships with enhanced visual clarity

Why some ecosystems collapse suddenly—and others don’t

One-third of U.S. public schools screen students for mental health issues

GLP-1 RA use and survival among older adults with cancer and type 2 diabetes

Trends in physician exit from fee-for-service Medicare

Systematic investigation of tumor microenvironment and antitumor immunity with IOBR

Common feature between forest fires and neural networks reveals the universal framework underneath

New R package revolutionizes gene set enrichment analysis visualization for biomedical research

[Press-News.org] Stanford scientists identify key protein controlling blood vessel growth into brains of mice